Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TAR decoys and trans-dominant gag mutant for HIV-1 gene therapy.

Antibiotics and chemotherapy - 1 Jan 1996

Lisziewicz J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Gene Transfer Techniques
Share to Genes, gag
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Long Terminal Repeat

Share to Mutation

Source

Identifiers

PMID: 8726525
DOI: 10.1159/000425177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TAR decoys and trans-dominant gag mutant for HIV-1 gene therapy.PMID 8726525Read ↗

CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.Semantic proximity Read ↗

Novel targets for anti-retroviral therapySemantic proximity Read ↗

Inhibition of HIV/SIV replication by dominant negative Gag mutants.Semantic proximity Read ↗

RNAi in Combination with a Ribozyme and TAR Decoy for Treatment of HIV Infection in Hematopoietic Cell Gene TherapySemantic proximity Read ↗

Target product profile for cell-based and gene-based therapies to achieve a cure for HIVSemantic proximity Read ↗

Advances in targeting nucleocapsid–nucleic acid interactions in HIV-1 therapySemantic proximity Read ↗

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus InfectionSemantic proximity Read ↗

Clinical targeting of HIV capsid protein with a long-acting small moleculeSemantic proximity Read ↗

Strategies to Block HIV Transcription: Focus on Small Molecule Tat InhibitorsSemantic proximity Read ↗

Novel approaches to inhibiting HIV-1 replicationSemantic proximity Read ↗

Generation of an HIV Resistant T-cell Line by Targeted “Stacking” of Restriction FactorsSemantic proximity Read ↗

T-Cell Receptor Gene Therapy: Critical Parameters for Clinical SuccessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.